Tiziana Life Sciences Ltd (NASDAQ:TLSA – Get Free Report)’s share price was down 4.7% during trading on Friday . The stock traded as low as $0.77 and last traded at $0.82. Approximately 231,886 shares were traded during mid-day trading, a decline of 31% from the average daily volume of 335,406 shares. The stock had previously closed at $0.86.
Tiziana Life Sciences Price Performance
The firm has a 50-day simple moving average of $1.02 and a 200 day simple moving average of $0.79.
Tiziana Life Sciences Company Profile
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.
Featured Articles
- Five stocks we like better than Tiziana Life Sciences
- The Basics of Support and Resistance
- GE Vernova’s Rally Could Continue as Wind Business Gains Ground
- Which Wall Street Analysts are the Most Accurate?
- DraftKings vs. DoubleDown: Growth in the Online Gambling Boom
- What Is WallStreetBets and What Stocks Are They Targeting?
- Join UiPath’s AI Surge and Catch the Coming Stock Price Reversal
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
